Moody's Ratings (Moody's) says that on 9 July, Merck & Co., Inc. ("Merck"; Aa3 stable) announced that it entered into a definitive agreement to acquire Verona Pharma plc ("Verona") for approximately $10 billion. The acquisition will meaningfully strengthen Merck's cardio-pulmonary product portfolio,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.